Combined Use of MRI and Ultrasound Boosts Market Examined by Kalorama Information

14 Mar 2012 • by Natalie Aster

When used together, MRI and ultrasound imaging becomes more effective, and this trend is among the many factors cited by healthcare market research publisher Kalorama Information for the growth in sales of both modalities.

In the most recent report “Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound Markets” Kalorama Information notes that worldwide revenues for MRI and ultrasound systems grew at 6% and 4% respectively between 2010 and 2011.

One example of combination usage is in rotator cuff tears. While ultrasound is usually viewed as more cost effective, MRI is most often used to evaluate the rotator cuff. When performing a cost utility analysis, utilizing ultrasound as the initial medical imaging test for a rotator cuff tear, along with a pre-operative MRI to identify alternative and concurrent diagnoses, can be a very effective hybrid imaging strategy.

Another area where a combination of modalities is used, according to Kalorama, is in breast cancer. A second-look ultrasound of the breast, used in conjunction with MRI, allows radiologists to identify lesions not detected with conventional mammography and first-look ultrasound; in some cases it allows radiologists to determine whether or not a lesion is malignant or benign. This was highlighted in a study performed at the University of Rome La Sapienza, Rome, Italy, that included 182 patients who had mammography, ultrasound and MRI. It has become accepted among some radiologists.

Report Details:

Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound Markets
Published: March, 2012
Pages: 150
Price: US$ 3.500,00

New research may find new combination uses. An experimental procedure developed by scientists at UCLA fuses MRI with real-time 3D ultrasound to obtain biopsy specimens from suspicious areas in the prostate. Patients first received MRI scans of the prostate that assessed three components in detecting cancer: suspicious contrasts in tissue, abnormal cellular density and unusual blood flow within the prostate.

More information can be found in the report “Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound Markets” by Kalorama Information.

To order the report or ask for sample pages contact


MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970